Variant report
Variant | rs603676 |
---|---|
Chromosome Location | chr11:86866109-86866110 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs11234985 | 0.94[ASN][1000 genomes] |
rs12280110 | 0.86[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs2048973 | 0.95[ASN][1000 genomes] |
rs2247537 | 0.94[ASN][1000 genomes] |
rs2445560 | 0.95[ASN][1000 genomes] |
rs2445561 | 0.95[ASN][1000 genomes] |
rs2451053 | 0.95[ASN][1000 genomes] |
rs2451060 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs2451061 | 0.95[ASN][1000 genomes] |
rs2451062 | 0.95[ASN][1000 genomes] |
rs2451063 | 0.95[ASN][1000 genomes] |
rs2451064 | 0.95[ASN][1000 genomes] |
rs2451065 | 0.83[ASN][1000 genomes] |
rs2512338 | 0.95[ASN][1000 genomes] |
rs2512342 | 0.95[ASN][1000 genomes] |
rs2512343 | 0.95[ASN][1000 genomes] |
rs2512344 | 0.95[ASN][1000 genomes] |
rs2512350 | 0.97[ASN][1000 genomes] |
rs2512490 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs2512494 | 0.92[ASN][1000 genomes] |
rs2512495 | 0.93[ASN][1000 genomes] |
rs2512496 | 0.93[ASN][1000 genomes] |
rs2932120 | 0.95[ASN][1000 genomes] |
rs3018709 | 0.95[ASN][1000 genomes] |
rs3018710 | 0.95[ASN][1000 genomes] |
rs3103386 | 0.95[ASN][1000 genomes] |
rs3133320 | 0.95[ASN][1000 genomes] |
rs3133321 | 0.95[ASN][1000 genomes] |
rs476597 | 0.82[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs477944 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs479593 | 0.81[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs480660 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs482258 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs482339 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs483373 | 0.97[ASN][1000 genomes] |
rs483548 | 0.95[ASN][1000 genomes] |
rs484135 | 0.82[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs484403 | 0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs486739 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs487370 | 0.95[ASN][1000 genomes] |
rs487678 | 0.95[ASN][1000 genomes] |
rs488227 | 0.95[ASN][1000 genomes] |
rs489247 | 0.84[ASN][1000 genomes] |
rs491895 | 0.93[ASN][1000 genomes] |
rs492211 | 0.97[ASN][1000 genomes] |
rs492896 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs494698 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs495238 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs495668 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs496671 | 0.95[ASN][1000 genomes] |
rs497592 | 0.97[ASN][1000 genomes] |
rs499388 | 0.97[ASN][1000 genomes] |
rs500312 | 0.95[ASN][1000 genomes] |
rs502165 | 0.95[ASN][1000 genomes] |
rs502580 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs5028348 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs505429 | 0.82[EUR][1000 genomes] |
rs509277 | 0.81[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs511694 | 0.84[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs511755 | 0.88[ASN][1000 genomes] |
rs513662 | 0.96[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs518489 | 0.95[ASN][1000 genomes] |
rs520755 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs522439 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs531500 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs533056 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs534009 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs535515 | 0.97[ASN][1000 genomes] |
rs537712 | 0.97[AFR][1000 genomes];0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs538494 | 0.95[ASN][1000 genomes] |
rs540403 | 0.82[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs541089 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs541998 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs542678 | 0.83[AMR][1000 genomes];0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs542697 | 0.83[AMR][1000 genomes];0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs543687 | 0.83[AMR][1000 genomes];0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs543915 | 0.94[ASN][1000 genomes] |
rs546229 | 0.98[AFR][1000 genomes];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs547867 | 0.84[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs549932 | 0.84[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs550988 | 0.95[ASN][1000 genomes] |
rs552521 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs555190 | 0.82[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs556139 | 0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs560624 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs561397 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs563688 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs564877 | 0.95[ASN][1000 genomes] |
rs565869 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs566046 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs568905 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs570716 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs572433 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs576582 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs576679 | 0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs578533 | 0.95[ASN][1000 genomes] |
rs580120 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs581833 | 0.89[ASN][1000 genomes] |
rs583334 | 0.95[ASN][1000 genomes] |
rs593243 | 0.97[ASN][1000 genomes] |
rs595930 | 0.93[ASN][1000 genomes] |
rs597319 | 0.81[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs597344 | 0.95[ASN][1000 genomes] |
rs597406 | 0.95[ASN][1000 genomes] |
rs603140 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs604035 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs604199 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs606284 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs606299 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs607619 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs607894 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs608533 | 0.87[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs608870 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs608966 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs609819 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs609914 | 0.80[ASN][1000 genomes] |
rs610228 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs611523 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs611579 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs612523 | 0.95[ASN][1000 genomes] |
rs618926 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs620303 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs624004 | 0.98[ASN][1000 genomes] |
rs625554 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs626897 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs628447 | 0.95[ASN][1000 genomes] |
rs628686 | 0.95[ASN][1000 genomes] |
rs630249 | 0.95[ASN][1000 genomes] |
rs632708 | 0.86[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs634277 | 0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs636159 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs643145 | 0.85[ASN][1000 genomes] |
rs643175 | 0.92[ASN][1000 genomes] |
rs644083 | 0.97[ASN][1000 genomes] |
rs644457 | 0.97[ASN][1000 genomes] |
rs649693 | 0.90[ASN][1000 genomes] |
rs651961 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs652171 | 0.81[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs653519 | 0.81[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs654405 | 0.82[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs654485 | 0.82[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs654569 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs655050 | 0.95[ASN][1000 genomes] |
rs655778 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs655907 | 0.95[ASN][1000 genomes] |
rs660246 | 0.95[ASN][1000 genomes] |
rs664398 | 0.85[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs670125 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs670857 | 0.81[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs672194 | 0.96[ASN][1000 genomes] |
rs672269 | 0.90[ASN][1000 genomes] |
rs673634 | 0.87[ASN][1000 genomes] |
rs687208 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs687244 | 0.97[ASN][1000 genomes] |
rs687651 | 0.90[ASN][1000 genomes] |
rs688542 | 0.97[ASN][1000 genomes] |
rs692857 | 0.95[ASN][1000 genomes] |
rs7949278 | 0.95[ASN][1000 genomes] |
rs7949665 | 0.94[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1044081 | chr11:86133641-86868560 | Bivalent/Poised TSS Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
2 | nsv541118 | chr11:86133641-86868560 | Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
3 | nsv1037042 | chr11:86586876-86978492 | Enhancers Flanking Active TSS Strong transcription Active TSS Weak transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
4 | nsv541119 | chr11:86586876-86978492 | Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
5 | nsv898058 | chr11:86754948-86889284 | Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
6 | nsv898059 | chr11:86754948-86949369 | Weak transcription Strong transcription Enhancers ZNF genes & repeats Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
7 | nsv1043562 | chr11:86755535-87547185 | Flanking Active TSS Enhancers Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 13 gene(s) | inside rSNPs | diseases |
8 | nsv541120 | chr11:86755535-87547185 | Bivalent Enhancer Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 13 gene(s) | inside rSNPs | diseases |
9 | nsv1046288 | chr11:86757573-87158571 | Enhancers ZNF genes & repeats Weak transcription Bivalent Enhancer Strong transcription Active TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 7 gene(s) | inside rSNPs | diseases |
10 | esv1844274 | chr11:86776992-86872908 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
11 | nsv1045057 | chr11:86794670-87033779 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
12 | nsv541121 | chr11:86794670-87033779 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Bivalent Enhancer Active TSS Genic enhancers Flanking Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
13 | nsv468777 | chr11:86794856-86985581 | Weak transcription Strong transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS | TF binding regionChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
14 | nsv555707 | chr11:86794856-86985581 | Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Strong transcription Bivalent Enhancer Genic enhancers Active TSS | TF binding regionChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
15 | nsv898060 | chr11:86822077-86912633 | Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Strong transcription Active TSS Genic enhancers | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
16 | nsv420 | chr11:86845328-86890111 | Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Genic enhancers Strong transcription Active TSS | Chromatin interactive region | n/a | inside rSNPs | diseases |
17 | nsv898061 | chr11:86850483-86944982 | Weak transcription Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Genic enhancers Active TSS | Chromatin interactive region | n/a | inside rSNPs | diseases |
18 | nsv468778 | chr11:86850483-86974576 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Strong transcription Genic enhancers Active TSS | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
19 | nsv555708 | chr11:86850483-86974576 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Active TSS Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | inside rSNPs | diseases |
20 | nsv898062 | chr11:86864277-86902079 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Flanking Active TSS Genic enhancers | Chromatin interactive region | n/a | inside rSNPs | diseases |
21 | nsv898063 | chr11:86864277-86944982 | Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Active TSS Strong transcription | Chromatin interactive region | n/a | inside rSNPs | diseases |
22 | nsv898064 | chr11:86864277-87013438 | Enhancers Weak transcription ZNF genes & repeats Active TSS Genic enhancers Strong transcription Flanking Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:86809000-86876000 | Weak transcription | Left Ventricle | heart |
2 | chr11:86836800-86877200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr11:86851200-86872600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr11:86853400-86866600 | Weak transcription | Right Atrium | heart |
5 | chr11:86860600-86866600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr11:86862200-86867800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr11:86862600-86866600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
8 | chr11:86862600-86867400 | Weak transcription | HUVEC | blood vessel |
9 | chr11:86862600-86871600 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr11:86863200-86866600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr11:86863200-86866600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr11:86863200-86866600 | Weak transcription | Psoas Muscle | Psoas |
13 | chr11:86863200-86866600 | Weak transcription | HepG2 | liver |
14 | chr11:86863200-86867000 | Weak transcription | Adipose Nuclei | Adipose |
15 | chr11:86864000-86866600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |